The In Vitro Cytotoxic Evaluation and Apoptotic Effects of Histone Deacetylase (HDAC) Inhibitory Drugs on Anaplastic Large Cell Lymphoma (ALCL) Cell Lines
Mutaz Jamal Al-Khreisat1, Abdul Aziz Mohamed Yusoff2, Faezahtul Arbaeyah Hussain3, Muhammad Farid Johan1,*
Journal of Angiotherapy 6(3) 718-719 https://doi.org/10.25163/angiotherapy.6333C
Submitted: 24 December 2022 Revised: 24 December 2022 Published: 24 December 2022
Abstract
Introduction: Anaplastic large cell lymphoma (ALCL) is a subtype of aggressive peripheral T-cell lymphoma (PTCL). ALCL develops from T-lymphocytes (T-cells) and approximately 10-20% of all T-non-Hodgkin lymphomas (T-NHL). CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) or CHOP-like anthracycline-containing combination chemotherapy is common treatment used in treating T-NHL including ALCL. The response to these regimes varies in ALCL patients. Hence, it is hypothesised that the disease may exhibit variable molecular biological behavior, which would affect how it responds to the conventional treatment. Alternative drugs with low toxicities and affecting epigenetic behavior like histone deacetylase need to be explored as new drug option to ALCL. Our study aimed to assess the cytotoxicity and apoptotic effects of histone deacetylase (HDAC) inhibitory drugs (Trichostatin A and Panobinostat) on ALCL cell lines. Methods: ALCL cell lines (SU-DHL-1, Ki-JK, and DL-40) were treated with different concentrations of Trichostatin A and Panobinostat to determine the cytotoxicity. 5-Azacytidine, an epigenetic drug that inhibits DNA methylation was used as positive control. Half maximal inhibitory concentration (IC50) values were determined by MTS cell viability assays after 48h of treatment and calculated with GraphPad Prism Software version 3 using a dose–response inhibition curve. Apoptosis assays were performed using Annexin V-FITC binding assays and analysed by flow cytometry. Results: Trichostatin A and Panobinostat were cytotoxic against all ALCL cell lines and Ki-JK were the most sensitive cell lines with IC50 211.7± 7.2 nM and 15.24± 3.4 nM, respectively. Trichostatin A and Panobinostat induced apopotosis in all ALCL cell lines with significantly higher apoptotic induction in Ki-JK (p<0.05). Conclusion: HDACs drugs have significance effects on all ALCL cell line as the dose concentration were low, no cytotoxicity, and have a great impact on apoptosis within a short period of time.
Keywords: ALCL, Lymphoma, Epigenetics, Trichostatin A, Panobinostat
References
View Dimensions
View Altmetric
Save
Citation
View
Share